1. Universiteit Leiden, The Netherlands
2. Leiden University, The Netherlands
3. University of Bristol, UK
4. The University of Edinburgh, UK

Abstract

GnRH₁ and GnRH₂ receptors (provisonal nomenclature [39], also called Type I and Type II GnRH receptor, respectively [85]) have been cloned from numerous species, most of which express two or three types of GnRH receptor [85, 84, 114]. GnRH I (p-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) is a hypothalamic decapeptide also known as luteinizing hormone-releasing hormone, gonadoliberin, luliberin, gonadorelin or simply as GnRH. It is a member of a family of similar peptides found in many species [85, 84, 114] including GnRH II (pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH₂ (which is also known as chicken GnRH-II). Receptors for three forms of GnRH exist in some species but only GnRH I and GnRH II and their cognate receptors have been found in mammals [85, 84, 114]. GnRH₁ receptors are expressed by pituitary gonadotrophs, where they mediate the effects of GnRH on gonadotropin hormone synthesis and secretion that underpin central control of mammalian reproduction. GnRH analogues are used in assisted reproduction and to treat steroid hormone-dependent conditions [58]. Notably, agonists cause desensitization of GnRH-stimulated gonadotropin secretion and the consequent reduction in circulating sex steroids is exploited to treat hormone-dependent cancers of the breast, ovary and prostate [58]. GnRH₁ receptors are selectively activated by GnRH I and all lack the COOH-terminal tails found in other GPCRs. GnRH₂ receptors do have COOH-terminal tails and (where tested) are selective for GnRH II over GnRH I. GnRH₂ receptors are expressed by some primates but not by humans [88]. Phylogenetic classifications divide GnRH receptors into three [85] or five groups [129] and highlight examples of gene loss through evolution, with humans retaining only one ancient gene. The structure of the GnRH₁ receptor in complex with elagolix has been elucidated [132].

Contents

GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a reference work which is most usefully represented as an on-line database. As in any publication this work should be appropriately cited, and the papers it cites should also be recognized. This document provides a citation for the relevant parts of the database, and also provides a reference list for the research cited by those parts. For further details see [11].

Please note that the database version for the citations given in GtoPdb are to the most recent preceding version in which the family or its subfamilies and targets were substantially changed. The links below are to the current version. If you need to consult the cited version, rather than the most recent version, please contact the GtoPdb curators.

Database links

References

1. Anderes KL, Luthin DR, Castillo R, Kraynov EA, Castro M, Nared-Hood K, Gregory ML, Pathak VP, Christie LC and Paderes G et al.. (2003) Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats. J Pharmacol Exp Ther 305: 688-95 [PMID:12606616]
2. Anderson L, Hillier SG, Eidne KA and Miro F. (1996) GnRH-induced calcium mobilisation and inositol phosphate production in immature and mature rat ovarian granulosa cells. J Endocrinol 149: 449-456 [PMID:8691103]
3. Anderson L, McGregor A, Cook JV, Chilvers E and Eidne KA. (1995) Rapid desensitization of GnRH-stimulated intracellular signalling events in alpha T3-1 and HEK-293 cells expressing the GnRH receptor. Endocrinology 136: 5228-31 [PMID:7588262]
4. Anderson L, Milligan G and Eidne KA. (1993) Characterization of the gonadotrophin-releasing hormone receptor in alpha T3-1 pituitary gonadotroph cells. J Endocrinol 136: 51-58 [PMID:8381456]
5. Ashton WT, Sisco RM, Kieczykowski GR, Yang YT, Yudkovitz JB, Cui J, Mount GR, Ren RN, Wu TJ and Shen X et al.. (2001) Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity. Bioorg Med Chem Lett 11: 2597-602 [PMID:11551758]
6. Beckers T, Bernd M, Kutscher B, Kühne R, Hoffmann S and Reissmann T. (2001) Structure-function studies of linear and cyclized peptide antagonists of the GnRH receptor. Biochem Biophys Res Commun 289: 653-63 [PMID:11726197]
7. Beckers T, Marheineke K, Reiländer H and Hilgard P. (1995) Selection and characterization of mammalian cell lines with stable over-expression of human pituitary receptors for gonadoliberin. Eur J Biochem 231: 535-43 [PMID:7649152]
8. Beckers T, Reiländer H and Hilgard P. (1997) Characterization of gonadotropin-releasing hormone analogs based on a sensitive cellular luciferase reporter gene assay. Anal Biochem 251: 17-23 [PMID:9300077]
9. Bekker RBW, Fjellaksel R, Hjornevik T, Nuruddin S, Rafique W, Hansen JH, Sundset R, Haraldsen IH and Riss PJ. (2020) Discovery of a Lead Brain-Penetrating Gonadotropin-Releasing Hormone Receptor Antagonist with Saturable Binding in Brain. ChemMedChem [PMID:32677155]
10. Betz SF, Zhu YF, Chen C and Struthers RS. (2008) Non-peptide gonadotropin-releasing hormone receptor antagonists. J Med Chem 51: 3331-3348 [PMID:18419112]
11. Buneman P, Christie G, Davies JA, Dimitrellou R, Harding SD, Pawson AJ, Sharman JL and Wu Y. (2020) Why data citation isn't working, and what to do about it Database 2020 [PMID:32367113]
12. Bédécarrats GY and Kaiser UB. (2007) Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function. Semin Reprod Med 25: 368-78 [PMID:17710733]
13. Caunt CJ, Hislop JN, Kelly E, Matharu AL, Green LD, Sedgley KR, Finch AR and McArdle CA. (2004) Regulation of gonadotropin-releasing hormone receptors by protein kinase C: inside out signalling and evidence for multiple active conformations. Endocrinology 145: 3594-602 [PMID:15059960]
14. Caunt CJ, Perett RM, Fowkes RC and McArdle CA. (2012) Mechanisms of GnRH-induced extracellular signal-regulated kinase nuclear localization. PLoS ONE 7: e40077 [PMID:22808094]
15. Chen C, Wu D, Guo Z, Xie Q, Reinhart GJ, Madan A, Wen J, Chen T, Huang CQ and Chen M et al.. (2008) Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor. J Med Chem 51: 7478-85 [PMID:19006286]
16. Chen HF, Jeung EB, Stephenson M and Leung PC. (1999) Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 84: 743-50 [PMID:10022447]
17. Cheng CK and Leung PC. (2005) Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 26: 283-306 [PMID:15561800]
18. Chevrier L, Guimiot F and de Roux N. (2011) GnRH receptor mutations in isolated gonadotropic deficiency. Mol Cell Endocrinol 346: 21-8 [PMID:21645587]
19. Chi L, Zhou W, Prikhozhan A, Flanagan C, Davidson JS, Golembo M, Illing N, Millar RP and Sealfon SC. (1993) Cloning and characterization of the human GnRH receptor. Mol Cell Endocrinol 91: R1-6 [PMID:8386108]
20. Cho N, Harada M, Imaeda T, Imada T, Matsumoto H, Hayase Y, Sasaki S, Furuya S, Suzuki N and Okubo S et al.. (1998) Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor. J Med Chem 41: 4190-5 [PMID:9784092]
21. Clayton RN, Solano AR, Garcia-Vela A, Dufau ML and Catt KJ. (1980) Regulation of pituitary receptors for gonadotropin-releasing hormone during the rat estrous cycle. Endocrinology 107: 699-706 [PMID:6249571]
22. Conn PM and Crowley Jr WF. (1994) Gonadotropin-releasing hormone and its analogs. Annu Rev Med 45: 391-405 [PMID:8198390]
23. Conn PM, Rogers DC and McNeil R. (1982) Potency enhancement of a GnRH agonist: GnRH-receptor microaggregation stimulates gonadotropin release. Endocrinology 111: 335-7 [PMID:6282571]
24. Conn PM and Ulloa-Aguirre A. (2011) Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors. Adv Pharmacol 62: 109-41 [PMID:21907908]
25. Conne BS, Scaglioni S, Lang U, Sizonenko PC and Aubert ML. (1982) Pituitary receptor sites for gonadotropin-releasing hormone: effect of castration and substitutive therapy with sex steroids in the male rat. Endocrinology 110: 70-79 [PMID:6274626]
26. Davidson JS, Assefa D, Pawson A, Davies P, Hapgood J, Becker I, Flanagan C, Roeske R and Millar R. (1997) Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. Biochemistry 36: 12881-9 [PMID:9335546]
27. Delahaye R, Manna PR, Bérault A, Berreur-Bonnenfant J, Berreur P and Counis R. (1997) Rat gonadotropin-releasing hormone receptor expressed in insect cells induces activation of adenylyl cyclase. Mol Cell Endocrinol 135: 119-27 [PMID:9484907]
28. DeVita RJ, Walsh TF, Young JR, Jiang J, Ujjainwalla F, Toupence RB, Parikh M, Huang SX, Fair JA and Goulet MT et al.. (2001) A potent, nonpeptidyl 1H-quinolone antagonist for the gonadotropin-releasing hormone receptor. J Med Chem 44: 917-22 [PMID:11300873]
29. Dong F, Skinner DC, Wu TJ and Ren J. (2011) The heart: a novel gonadotrophin-releasing hormone target. J Neuroendocrinol 23: 456-63 [PMID:21332841]
30. Eidne KA, Sellar RE, Couper G, Anderson L and Taylor PL. (1992) Molecular cloning and characterisation of the rat pituitary gonadotropin-releasing hormone (GnRH) receptor. Mol Cell Endocrinol 90: R5-9 [PMID:1338727]
31. Engel JB, Hahne JC, Häusler SF, Meyer S, Segerer SE, Diessner J, Dietl J and Honig A. (2012) Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells. Anticancer Res 32: 2063-8 [PMID:22593489]
32. Engel JB and Schally AV. (2007) Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab 3: 157-67 [PMID:17237842]
33. Fan NC, Jeung EB, Peng C, Olofsson JI, Krisinger J and Leung PC. (1994) The human gonadotropin-releasing hormone (GnRH) receptor gene: cloning, genomic organization and chromosomal assignment. Mol Cell Endocrinol 103: R1-6 [PMID:7958384]
34. Fan NC, Peng C, Krisinger J and Leung PC. (1995) The human gonadotropin-releasing hormone receptor gene: complete structure including multiple promoters, transcription initiation sites, and polyadenylation signals. Mol Cell Endocrinol 107: R1-8 [PMID:7768323]
35. Finch AR, Caunt CJ, Armstrong SP and McArdle CA. (2010) Plasma membrane expression of gonadotropin-releasing hormone receptors: regulation by peptide and nonpeptide antagonists. Mol Endocrinol 24: 423-35 [PMID:20009083]
36. Finch AR, Sedgley KR, Armstrong SP, Caunt CJ and McArdle CA. (2010) Trafficking and signalling of gonadotrophin-releasing hormone receptors: an automated imaging approach. Br J Pharmacol 159: 751-60 [PMID:19888967]
37. Fister S, Günthert AR, Aicher B, Paulini KW, Emons G and Gründker C. (2009) GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax. Cancer Res 69: 6473-81 [PMID:19638591]
38. Fjellaksel R, Moldes-Anaya A, Vasskog T, Oteiza A, Martin-Armas M, Hjelstuen OK, Hansen JH, Riss PJ and Sundset R. (2020) Evaluation by metabolic profiling and in vitro autoradiography of two promising GnRH-receptor ligands for brain SPECT imaging. J Labelled Comp Radiopharm 63: 72-84 [PMID:31813158]
39. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M and Harmar AJ. (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57: 279-88 [PMID:15914470]
40. Fromme BJ, Katz AA, Roeske RW, Millar RP and Flanagan CA. (2001) Role of aspartate7.32(302) of the human gonadotropin-releasing hormone receptor in stabilizing a high-affinity ligand conformation. Mol Pharmacol 60: 1280-1287 [PMID:11723235]
41. Grosse R, Schmid A, Schöneberg T, Herrlich A, Muhn P, Schultz G and Gudermann T. (2000) Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q/11) proteins. J Biol Chem 275: 9193-200 [PMID:10734055]
42. Gründker C, Völker P, Griesinger F, Ramaswamy A, Nagy A, Schally AV and Emons G. (2002) Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice. Am J Obstet Gynecol 187: 528-37 [PMID:12237622]
43. Halmos G and Schally AV. (2002) Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix. Proc Natl Acad Sci USA 99: 961-5 [PMID:11805337]
44. Harrison GS, Wierman ME, Nett TM and Glode LM. (2004) Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer 11: 725-48 [PMID:15613448]
45. Heding A, Vrecl M, Bogerd J, McGregor A, Sellar R, Taylor PL and Eidne KA. (1998) Gonadotropin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and exhibit accelerated internalization kinetics. J Biol Chem 273: 11472-7 [PMID:9565559]
46. Heitman LH and Ijzerman AP. (2008) G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands. Med Res Rev 28: 975-1011 [PMID:18561294]
47. Heitman LH, Ye K, Oosterom J and Ijzerman AP. (2008) Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor. Mol Pharmacol 73: 1808-15 [PMID:18344315]
48. Herbst KL. (2003) Gonadotropin-releasing hormone antagonists. Curr Opin Pharmacol 3: 660-6 [PMID:14644020]
49. Hirdes W, Dinu C, Bauer CK, Boehm U and Schwarz JR. (2010) Gonadotropin-releasing hormone inhibits ether-à-go-go-related gene K+ currents in mouse gonadotropes. Endocrinology 151: 1079-88 [PMID:20068004]
50. Hoffmann SH, ter Laak T, Kühne R, Reiländer H and Beckers T. (2000) Residues within transmembrane helices 2 and 5 of the human gonadotropin-releasing hormone receptor contribute to agonist and antagonist binding. Mol Endocrinol 14: 1099-115 [PMID:10894158]
51. Huang S, Wu H, Li B, Fu L, Sun P, Wang M and Hu K. (2020) Automated radiosynthesis and preclinical evaluation of Al[¹⁸F]F-NOTA-P-GnRH for PET imaging of GnRH receptor-positive tumors. Nucl Med Biol 82-83: 64-71 [PMID:32088580]
52. Huirne JA and Lambalk CB. (2001) Gonadotropin-releasing-hormone-receptor antagonists. Lancet 358: 1793-803 [PMID:11734258]
53. Janovick JA, Maya-Nunez G and Conn PM. (2002) Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J Clin Endocrinol Metab 87: 3255-62 [PMID:12107234]
54. Kaiser UB, Zhao D, Cardona GR and Chin WW. (1992) Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem Biophys Res Commun 189: 1645-52 [PMID:1339279]
55. Kakar SS, Grizzle WE and Neill JD. (1994) The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol 106: 145-9 [PMID:7534732]
56. Kakar SS and Jennes L. (1995) Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Lett 98: 57-62 [PMID:8529206]
57. Kakar SS, Musgrove LC, Devor DC, Sellers JC and Neill JD. (1992) Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 189: 289-95 [PMID:1333190]
58. Kiesel LA, Rody A, Greb RR and Szilágyi A. (2002) Clinical use of GnRH analogues. Clin Endocrinol (Oxf) 56: 677-87 [PMID:12072036]
59. Kim SM, Yoo T, Lee SY, Kim EJ, Lee SM, Lee MH, Han MY, Jung SH, Choi JH and Ryu KH et al.. (2015) Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis. Life Sci 139: 166-74 [PMID:26321528]
60. Kottler ML, Lorenzo F, Bergametti F, Commerçon P, Souchier C and Counis R. (1995) Subregional mapping of the human gonadotropin-releasing hormone receptor (GnRH-R) gene to 4q between the markers D4S392 and D4S409. Hum Genet 96: 477-80 [PMID:7557974]
61. Kovacs M, Seprodi J, Koppan M, Horvath JE, Vincze B, Teplan I and Flerko B. (2002) Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats. J Neuroendocrinol 14: 647-55 [PMID:12153467]
62. Kroeger KM, Hanyaloglu AC, Seeber RM, Miles LE and Eidne KA. (2001) Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. J Biol Chem 276: 12736-43 [PMID:11278883]
63. Krsmanovic LZ, Mores N, Navarro CE, Arora KK and Catt KJ. (2003) An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion. Proc Natl Acad Sci USA 100: 2969-74 [PMID:12591945]
64. Kudo A, Park MK and Kawashima S. (1993) Isolation of rat GnRH receptor cDNA having different 5'-noncoding sequence. Zool Sci 10: 863-7 [PMID:7764374]
65. Kuphal D, Janovick JA, Kaiser UB, Chin WW and Conn PM. (1994) Stable transfection of GH3 cells with rat gonadotropin-releasing hormone receptor complementary deoxyribonucleic acid results in expression of a receptor coupled to cyclic adenosine 3',5'-monophosphate-dependent prolactin release via a G-protein. Endocrinology 135: 315-20 [PMID:8013367]
66. La Rosa S, Celato N, Uccella S and Capella C. (2000) Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry. Virchows Arch 437: 264-9 [PMID:11037346]
67. Lamb YN. (2018) Elagolix: First Global Approval. Drugs 78: 1501-1508 [PMID:30194661]
68. Lau HL, Zhu XM, Leung PC, Chan LW, Chen GF, Chan PS, Yu KL and Chan FL. (2001) Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates. Int J Oncol 19: 1193-201 [PMID:11713589]
69. Leaños-Miranda A, Ulloa-Aguirre A, Ji TH, Janovick JA and Conn PM. (2003) Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans. J Clin Endocrinol Metab 88: 3360-7 [PMID:12843188]
70. Lee CY, Ho J, Chow SN, Yasojima K, Schwab C and McGeer PL. (2000) Immunoidentification of gonadotropin releasing hormone receptor in human sperm, pituitary and cancer cells. Am J Reprod Immunol 44: 170-7 [PMID:11028904]
71. Leung PC, Squire J, Peng C, Fan N, Hayden MR and Olofsson JI. (1995) Mapping of the gonadotropin-releasing hormone (GnRH) receptor gene to human chromosome 4q21.2 by fluorescence in situ hybridization. Mamm Genome 6: 309-10 [PMID:7613048]
72. Levi LN, Ben-Aroya N, Tel-Or S, Palmon A, Burstein Y and Koch Y. (1996) Expression of the gene for the receptor of gonadotropin-releasing hormone in the rat mammary gland. FEBS Lett 379: 186-90 [PMID:8635589]
73. Limonta P, Moretti RM, Marelli MM and Motta M. (2003) The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol 24: 279-95 [PMID:14726258]
74. Liu Q, Zhou X, Feng W, Pu T, Li X, Li F, Kang Y, Zhang X and Xu C. (2020) Gonadotropin-Releasing Hormone Receptor-Targeted Near-Infrared Fluorescence Probe for Specific Recognition and Localization of Peritoneal Metastases of Ovarian Cancer. Front Oncol 10: 266 [PMID:32185134]
75. Liu SV, Liu S and Pinski J. (2011) Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer. Expert Opin Investig Drugs 20: 769-78 [PMID:21449823]
76. Lovas S, Pályi I, Vincze B, Horváth J, Kovács M, Mezö I, Tóth G, Teplán I and Murphy RF. (1998) Direct anticancer activity of gonadotropin-releasing hormone-III. J Pept Res 52: 384-9 [PMID:9894843]
77. Lu ZL, Coetsee M, White CD and Millar RP. (2007) Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor. J Biol Chem 282: 17921-9 [PMID:17452338]
78. Maiti K, Li JH, Wang AF, Acharjee S, Kim WP, Im WB, Kwon HB and Seong JY. (2003) GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors. Mol Cells 16: 173-9 [PMID:14651258]
79. Marian J and Conn PM. (1983) Subcellular localization of the receptor for gonadotropin-releasing hormone in pituitary and ovarian tissue. Endocrinology 112: 104-112 [PMID:6291912]
80. Mason AJ, Hayflick JS, Zoeller RT, Young 3rd WS, Phillips HS, Nikolics K and Seeburg PH. (1986) A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 234: 1366-71 [PMID:3024317]
81. Maudsley S, Davidson L, Pawson AJ, Chan R, López de Maturana R and Millar RP. (2004) Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor. Cancer Res 64: 7533-44 [PMID:15492280]
82. Mezo G, Czajlik A, Manea M, Jakab A, Farkas V, Majer Z, Vass E, Bodor A, Kapuvári B and Boldizsár M et al.. (2007) Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives. Peptides 28: 806-20 [PMID:17254668]
83. Millar R, Lowe S, Conklin D, Pawson A, Maudsley S, Troskie B, Ott T, Millar M, Lincoln G and Sellar R et al.. (2001) A novel mammalian receptor for the evolutionarily conserved type II GnRH. Proc Natl Acad Sci USA 98: 9636-41 [PMID:11493674]
84. Millar RP. (2005) GnRHs and GnRH receptors. Anim Reprod Sci 88: 5-28 [PMID:16140177]
85. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K and Maudsley SR. (2004) Gonadotropin-releasing hormone receptors. Endocr Rev 25: 235-75 [PMID:15082521]
86. Miller GM, Alexander JM and Klibanski A. (1996) Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary. J Clin Endocrinol Metab 81: 80-83 [PMID:8550798]
87. Miwa K, Hitaka T, Imada T, Sasaki S, Yoshimatsu M, Kusaka M, Tanaka A, Nakata D, Furuya S and Endo S et al.. (2011) Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor. J Med Chem 54: 4998-5012 [PMID:21657270]
88. Morgan K, Conklin D, Pawson AJ, Sellar R, Ott TR and Millar RP. (2003) A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology 144: 423-36 [PMID:12538601]
89. Morrison N, Sellar RE, Boyd E, Eidne KA and Connor JM. (1994) Assignment of the gene encoding the human gonadotropin-releasing hormone receptor to 4q13.2-13.3 by fluorescence in situ hybridization. Hum Genet 93: 714-5 [PMID:8005601]
90. Naor Z, Clayton RN and Catt KJ. (1980) Characterization of gonadotropin-releasing hormone receptors in cultured rat pituitary cells. Endocrinology 107: 1144-52 [PMID:6250793]
91. Nederpelt I, Georgi V, Schiele F, Nowak-Reppel K, Fernández-Montalván AE, IJzerman AP and Heitman LH. (2016) Characterization of 12 GnRH peptide agonists - a kinetic perspective. Br J Pharmacol 173: 128-41 [PMID:26398856]
92. Nederpelt I, Vergroesen RD, IJzerman AP and Heitman LH. (2016) Persistent GnRH receptor activation in pituitary αT3-1 cells analyzed with a label-free technology. Biosens Bioelectron 79: 721-7 [PMID:26774084]
93. Neill JD. (2002) GnRH and GnRH receptor genes in the human genome. Endocrinology 143: 737-43 [PMID:11861490]
94. Netiv E, Liscovitch M and Naor Z. (1991) Delayed activation of phospholipase D by gonadotropin-releasing hormone in a clonal pituitary gonadotrope cell line (alpha T3-1). FEBS Lett 295: 107-9 [PMID:1765140]
95. Olberg DE, Bauer N, Andressen KW, Hjørnevik T, Cumming P, Levy FO, Klaveness J, Haraldsen I and Sutcliffe JL. (2016) Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Nucl Med Biol 43: 478-89 [PMID:27236283]
96. Papanikolaou EG, Kolibianakis E and Devroey P. (2005) Emerging drugs in assisted reproduction. Expert Opin Emerg Drugs 10: 425-40 [PMID:15934877]
97. Pask AJ, Kanasaki H, Kaiser UB, Conn PM, Janovick JA, Stockton DW, Hess DL, Justice MJ and Behringer RR. (2005) A novel mouse model of hypogonadotrophic hypogonadism: N-ethyl-N-nitrosourea-induced gonadotropin-releasing hormone receptor gene mutation. Mol Endocrinol 19: 972-81 [PMID:15625238]
98. Pelletier JC, Chengalvala M, Cottom J, Feingold I, Garrick L, Green D, Hauze D, Huselton C, Jetter J and Kao W et al.. (2008) 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. Bioorg Med Chem 16: 6617-40 [PMID:18511284]
99. Pelletier JC, Chengalvala MV, Cottom JE, Feingold IB, Green DM, Hauze DB, Huselton CA, Jetter JW, Kopf GS and Lundquist JT et al.. (2009) Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R). J Med Chem 52: 2148-52 [PMID:19271735]
100. Peng C, Fan NC, Ligier M, Väänänen J and Leung PC. (1994) Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 135: 1740-6 [PMID:7956897]
101. Perrin MH, Bilezikjian LM, Hoeger C, Donaldson CJ, Rivier J, Haas Y and Vale WW. (1993) Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line. Biochem Biophys Res Commun 191: 1139-44 [PMID:7916600]
102. Perrin MH, Haas Y, Rivier JE and Vale WW. (1983) Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist. Mol Pharmacol 23: 44-51 [PMID:6346049]
103. Poulin B, Rich N, Mitev Y, Gautron JP, Kordon C, Enjalbert A and Drouva SV. (1996) Differential involvement of calcium channels and protein kinase-C activity in GnRH-induced phospholipase-C, -A2 and -D activation in a gonadotrope cell line (alpha T3-1). Mol Cell Endocrinol 122: 33-50 [PMID:8898346]
104. Reeves JJ, Séguin C, Lefebvre FA, Kelly PA and Labrie F. (1980) Similar luteinizing hormone-releasing hormone binding sites in rat anterior pituitary and ovary. Proc Natl Acad Sci USA 77: 5567-71 [PMID:6254091]
105. Reinhart J, Mertz LM and Catt KJ. (1992) Molecular cloning and expression of cDNA encoding the murine gonadotropin-releasing hormone receptor. J Biol Chem 267: 21281-4 [PMID:1328228]
106. Rivier J, Theobald P, Porter J, Perrin M, Gunnet J, Hahn DW and Rivier C. (1991) Gonadotropin releasing hormone antagonists: novel structures incorporating N omega-cyano modified guanidine moieties. Biochem Biophys Res Commun 176: 406-12 [PMID:1850267]
107. Saleh-Abady MM, Naderi-Manesh H, Alizadeh A, Shamsipour F, Balalaie S and Arabanian A. (2010) Anticancer activity of a new gonadotropin releasing hormone analogue. Biopolymers 94: 292-7 [PMID:19908246]
108. Sanno N, Jin L, Qian X, Osamura RY, Scheithauer BW, Kovacs K and Lloyd RV. (1997) Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries. J Clin Endocrinol Metab 82: 1974-1982 [PMID:9177416]
109. Sasaki S, Cho N, Nara Y, Harada M, Endo S, Suzuki N, Furuya S and Fujino M. (2003) Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor. J Med Chem 46: 113-24 [PMID:12502365]
110. Schally AV, Arimura A, Kastin AJ, Matsuo H, Baba Y, Redding TW, Nair RM, Debeljuk L and White WF. (1971) Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science 173: 1036-8 [PMID:4938639]
111. Schally AV, Engel JB, Emons G, Block NL and Pinski J. (2011) Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors. Curr Drug Deliv 8: 11-25 [PMID:21034424]
112. Schally AV and Nagy A. (2004) Chemotherapy targeted to cancers through tumoral hormone receptors. Trends Endocrinol Metab 15: 300-10 [PMID:15350601]
113. Shah BH and Milligan G. (1994) The gonadotrophin-releasing hormone receptor of alpha T3-1 pituitary cells regulates cellular levels of both of the phosphoinositidase C-linked G proteins, Gq alpha and G11 alpha, equally. Mol Pharmacol 46: 1-7 [PMID:8058044]
114. Silver MR, Nucci NV, Root AR, Reed KL and Sower SA. (2005) Cloning and characterization of a functional type II gonadotropin-releasing hormone receptor with a lengthy carboxy-terminal tail from an ancestral vertebrate, the sea lamprey. Endocrinology 146: 3351-61 [PMID:15878963]
115. Stewart AJ, Sellar R, Wilson DJ, Millar RP and Lu ZL. (2008) Identification of a novel ligand binding residue Arg38(1.35) in the human gonadotropin-releasing hormone receptor. Mol Pharmacol 73: 75-81 [PMID:17942747]
116. Struthers RS, Xie Q, Sullivan SK, Reinhart GJ, Kohout TA, Zhu YF, Chen C, Liu XJ, Ling N and Yang W et al.. (2007) Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902. Endocrinology 148: 857-67 [PMID:17095587]
117. Sullivan SK, Brown MS, Gao Y, Loweth CJ, Lio FM, Crowe PD, Struthers RS and Betz SF. (2006) Allosteric and orthosteric binding modes of two nonpeptide human gonadotropin-releasing hormone receptor antagonists. Biochemistry 45: 15327-37 [PMID:17176055]
118. Sullivan SK, Hoare SR, Fleck BA, Zhu YF, Heise CE, Struthers RS and Crowe PD. (2006) Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism. Biochem Pharmacol 72: 838-49 [PMID:16930559]
119. Tan O and Bukulmez O. (2011) Biochemistry, molecular biology and cell biology of gonadotropin-releasing hormone antagonists. Curr Opin Obstet Gynecol 23: 238-44 [PMID:21666463]
120. Themmen APN and Huhtaniemi IT. (2000) Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21: 551-83 [PMID:11041448]
121. Tsui KH, Lee WL, Seow KM, Yang LW, Wang SY, Wang PH, Chang CL, Yen MS, Cheng JT and Chen CP. (2014) Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells. Taiwan J Obstet Gynecol 53: 35-42 [PMID:24767644]
122. Tsutsumi M, Zhou W, Millar RP, Mellon PL, Roberts JL, Flanagan CA, Dong K, Gillo B and Sealfon SC. (1992) Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol 6: 1163-9 [PMID:1324422]
123. Tsutsumi R, Mistry D and Webster NJ. (2010) Signaling responses to pulsatile gonadotropin-releasing hormone in LbetaT2 gonadotrope cells. J Biol Chem 285: 20262-72 [PMID:20406815]
124. Tucci FC, Zhu YF, Struthers RS, Guo Z, Gross TD, Rowbottom MW, Acevedo O, Gao Y, Saunders J and Xie Q et al.. (2005) 3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization. J Med Chem 48: 1169-78 [PMID:15715483]
125. Van Poppel H. (2010) Evaluation of degarelix in the management of prostate cancer. Cancer Manag Res 2: 39-52 [PMID:21188095]
126. Wang C, Ma Y, Feng S, Liu K and Zhou N. (2015) Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation. J Pept Sci 21: 569-76 [PMID:25851250]
127. Weckermann D and Harzmann R. (2004) Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues. Eur Urol 46: 279-83; discussion 283-4 [PMID:15306097]
128. White RB, Eisen JA, Kasten TL and Fernald RD. (1998) Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci USA 95: 305-9 [PMID:9419371]
129. Williams BL, Akazome Y, Oka Y and Eisthen HL. (2014) Dynamic evolution of the GnRH receptor gene family in vertebrates. BMC Evol Biol 14: 215 [PMID:25344287]
130. Wu HM, Wang HS, Huang HY, Lai CH, Lee CL, Soong YK and Leung PC. (2013) Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2. BMC Cancer 13: 300 [PMID:23786715]
131. Yahalom D, Chen A, Ben-Aroya N, Rahimipour S, Kaganovsky E, Okon E, Fridkin M and Koch Y. (1999) The gonadotropin-releasing hormone family of neuropeptides in the brain of human, bovine and rat: identification of a third isoform. FEBS Lett 463: 289-94 [PMID:10606740]
132. Yan W, Cheng L, Wang W, Wu C, Yang X, Du X, Ma L, Qi S, Wei Y and Lu Z et al.. (2020) Structure of the human gonadotropin-releasing hormone receptor GnRH1R reveals an unusual ligand binding mode. Nat Commun 11: 5287 [PMID:33082324]